The presentation focused on how these medications work, how weight-centric messaging shapes care, and why clinicians must approach prescribing and assessment with cautionparticularly for individuals with current or past eating disorders
The UK has its own separate framework following Brexit, with the MHRA providing guidance on research chemical imports
What are the side effects of Isotretinoin (Accutane)
Your nurse will tell you exactly what to expect when you book
The info above reflects publicly available plan information as of February 2026
Tirzepatide is a dual-agonist , meaning it works by targeting two hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Retatrutide is a triple-agonist , meaning it targets three hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Glucagon: affects energy use and fat metabolism Early studies show that retatrutide may be more successful than tirzepatide at managing diabetic kidney disease, as well as for weight control, while tirzepatide may be better at managing blood glucose